Approvals/TGA/OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation)

Approved

STANDARD

OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation)

Eli Lilly Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f8c0f76d5e75752c
Product Name: OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation)
Artg Id: 461265
Artg Name: OMVOH mirikizumab 100 mg/mL + 200 mg/2 mL solution for injection pre-filled syringe (composite pack) (citrate free formulation)
Sponsor: Eli Lilly Australia Pty Ltd
Company Detail Path: /organization/eli-lilly-australia-pty-ltd
Artg Date: 2025-07-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f8c0f76d5e75752c

Type

Standard